This Tuesday, the OncoSec team will play host to some of the most brilliant minds in immuno-oncology, with our highly anticipated symposium, “An Introspective on Immunotherapy: A Symposium on Intratumoral Therapy.” The event promises to be a notable high point during the week of J.P. Morgan’s annual healthcare conference, a week that has historically attracted the “who’s who” of the healthcare sector.
Speaker presentations will focus on the rationale and potential of intratumoral immunotherapy, with an emphasis on OncoSec’s role as a key leader in this field. The event’s agenda is as follows.
University of Utah
After the symposium has concluded, a webcast will be made available via the following link: www.oncosec.com/jmp-immunotherapy-symposium-2015/
We want to thank all attendees in advance for taking the time to learn more about the exciting field of intratumoral immunotherapy, and understand its place as a critical component of the emerging cancer treatment landscape. Immunotherapy is transforming oncology, and intratumoral approaches like OncoSec’s ImmunoPulse have the potential to fundamentally change how we treat cancer.
We are entering into a new era at OncoSec, as the world begins to recognize the true value of therapies that directly combat the immunosuppressive nature of cancers. During this pivotal time, we hope our symposium can inspire, inform, and leave attendees with a newfound understanding of both intratumoral immunotherapy and OncoSec’s role as a key leader in this space.
For more info or to RSVP: email email@example.com